Efficacy of adalimumab for the management of inflammatory bowel disease in the clinical setting.
Trinder, Matthew W
Efficacy of adalimumab for the management of inflammatory bowel disease in the clinical setting. [electronic resource] - Journal of gastroenterology and hepatology Jul 2009 - 1252-7 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1440-1746
10.1111/j.1440-1746.2009.05786.x doi
Adalimumab
Adolescent
Adult
Anti-Inflammatory Agents--administration & dosage
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized
Australia
Child
Colitis, Ulcerative--diagnosis
Crohn Disease--diagnosis
Drug Administration Schedule
Female
Gastrointestinal Agents--administration & dosage
Humans
Infliximab
Male
Middle Aged
Prospective Studies
Remission Induction
Severity of Illness Index
Time Factors
Treatment Failure
Tumor Necrosis Factor-alpha--antagonists & inhibitors
Young Adult
Efficacy of adalimumab for the management of inflammatory bowel disease in the clinical setting. [electronic resource] - Journal of gastroenterology and hepatology Jul 2009 - 1252-7 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1440-1746
10.1111/j.1440-1746.2009.05786.x doi
Adalimumab
Adolescent
Adult
Anti-Inflammatory Agents--administration & dosage
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized
Australia
Child
Colitis, Ulcerative--diagnosis
Crohn Disease--diagnosis
Drug Administration Schedule
Female
Gastrointestinal Agents--administration & dosage
Humans
Infliximab
Male
Middle Aged
Prospective Studies
Remission Induction
Severity of Illness Index
Time Factors
Treatment Failure
Tumor Necrosis Factor-alpha--antagonists & inhibitors
Young Adult